An executive order by Trump rolled back some efforts by the Biden administration to control Medicare costs but it didn't ...
At least three government lawyers working on defending a major Biden-era drug pricing law were laid off in mass cuts across ...
The bill would allow Medicare to begin negotiating with pharmaceutical companies over prices for small molecule medicines 13 ...
This year, people on Medicare Part D will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that ...
The Inflation Reduction Act of 2022 marked a significant shift in US health care policy, granting the Centers for Medicare and Medicaid Services (CMS) the authority to establish a program to negotiate ...
The purpose of the Affordable Care Act (ACA) was to make healthcare more affordable. It has had various effects on Medicare, ...
Older Americans have ways to protect against high out-of-pocket health care costs, but it’s important to understand the trade ...
A federal court rejected Novartis' legal challenge to the Medicare Drug Price Negotiation Program, ruling that it does not ...
Speaker Mike Johnson (R-La.) indicated this week that his approach to repealing the Democrats’ climate, tax, infrastructure ...
While many industry players and observers have high hopes for the EPIC Act, some say budgetary headwinds could make it ...
Manufacturers are responsible for meeting all four parts of the definition of bona fide service fee before a fee can qualify as a bona fide ...